These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38268359)

  • 1. [Not Available].
    Janssens JP
    Rev Med Suisse; 2024 Jan; 20(858):141-142. PubMed ID: 38268359
    [No Abstract]   [Full Text] [Related]  

  • 2. [Introduction-Epidemiology of latent and active tuberculosis].
    Maitre T; Robert J; Veziris N
    Rev Mal Respir; 2018 Oct; 35(8):859-861. PubMed ID: 30241683
    [No Abstract]   [Full Text] [Related]  

  • 3. [Characteristics of tuberculosis in children].
    Delacourt C
    Rev Prat; 2012 Apr; 62(4):504-6. PubMed ID: 22641891
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tuberculosis. Shorten time to diagnosis].
    Bouvet E
    Rev Prat; 2012 Apr; 62(4):471-2. PubMed ID: 22641880
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for Latent Tuberculosis Infection Among Non-US-Born Adults in the US: A Path Toward Elimination.
    Shete PB; Tang AS; Flood J
    JAMA; 2023 May; 329(17):1457-1459. PubMed ID: 37129665
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease.
    ; Milburn H; Ashman N; Davies P; Doffman S; Drobniewski F; Khoo S; Ormerod P; Ostermann M; Snelson C
    Thorax; 2010 Jun; 65(6):557-70. PubMed ID: 20522863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reactivation of tuberculosis during treatment with inhibitors of TNF].
    Miossec P
    Rev Prat; 2018 May; 68(5):537-540. PubMed ID: 30869425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Report of the VIth Tuberculosis Day Conference].
    Zielonka TM
    Przegl Epidemiol; 2012; 66(2):381-3. PubMed ID: 23101234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.
    Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM
    J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notes from the Field: Use of Asynchronous Video Directly Observed Therapy for Treatment of Tuberculosis and Latent Tuberculosis Infection in a Long-Term-Care Facility - Puerto Rico, 2016-2017.
    Olano-Soler H; Thomas D; Joglar O; Rios K; Torres-Rodríguez M; Duran-Guzman G; Chorba T
    MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(50):1386-1387. PubMed ID: 29267264
    [No Abstract]   [Full Text] [Related]  

  • 11. Tuberculosis Screening, Testing, and Treatment of US Health Care Personnel: ACOEM and NTCA Joint Task Force on Implementation of the 2019 MMWR Recommendations.
    Thanassi W; Behrman AJ; Reves R; Russi M; Swift M; Warkentin J; Miyakawa R; Wegener D; Budnick L; Murray E; Scarpita A; Hurst BJ; Foster-Chang S; Mathew T; Gruden M; Higashi J; Hudson TW
    J Occup Environ Med; 2020 Jul; 62(7):e355-e369. PubMed ID: 32730040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent tuberculosis infection and treatment in a healthcare worker.
    Ferrara SA; Burke RE
    Nurse Pract; 2015 Jul; 40(7):10-5. PubMed ID: 26080291
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycobacterium tuberculosis infection in liver transplantation.
    Yehia BR; Blumberg EA
    Liver Transpl; 2010 Oct; 16(10):1129-35. PubMed ID: 20879011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IP-10 in the diagnosis of latent and active tuberculosis.
    Clifford V; Tebruegge M; Zufferey C; Germano S; Denholm J; Street A; McBryde E; Eisen D; Curtis N
    J Infect; 2015 Dec; 71(6):696-8. PubMed ID: 26271898
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection.
    Moran Mendoza O
    Eur Respir J; 2011 Nov; 38(5):1237-8; author's reply 1238-9. PubMed ID: 22045795
    [No Abstract]   [Full Text] [Related]  

  • 16. Discriminating between latent and active tuberculosis: the role of interleukin-2 as biomarker.
    Mamishi S; Pourakbari B; Marjani M; Bahador A; Mahmoudi S
    J Infect; 2015 Apr; 70(4):429-31. PubMed ID: 25562449
    [No Abstract]   [Full Text] [Related]  

  • 17. Consensus Document on Prevention and Treatment of Tuberculosis in Patients for Biological Treatment.
    Mir Viladrich I; Daudén Tello E; Solano-López G; López Longo FJ; Taxonera Samso C; Sánchez Martínez P; Martínez Lacasa X; García Gasalla M; Dorca Sargatal J; Arias-Guillén M; García García JM
    Arch Bronconeumol; 2016 Jan; 52(1):36-45. PubMed ID: 26187708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of latent infection treatment in indigenous populations.
    Yuhara LS; Sacchi FP; Croda J
    PLoS One; 2013; 8(7):e71201. PubMed ID: 23936264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies.
    Esmail H; Barry CE; Wilkinson RJ
    Drug Discov Today; 2012 May; 17(9-10):514-21. PubMed ID: 22198298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring.
    Bayaa R; Ndiaye MDB; Chedid C; Kokhreidze E; Tukvadze N; Banu S; Uddin MKM; Biswas S; Nasrin R; Ranaivomanana P; Raherinandrasana AH; Rakotonirina J; Rasolofo V; Delogu G; De Maio F; Goletti D; Endtz H; Ader F; Hamze M; Ismail MB; Pouzol S; Rakotosamimanana N; Hoffmann J;
    Sci Rep; 2021 Jul; 11(1):13646. PubMed ID: 34211042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.